Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: J Clin Lipidol. 2017 Jul 5;11(5):1201–1211. doi: 10.1016/j.jacl.2017.06.017

Table 1.

Baseline Characteristics by Number of Metabolic Syndrome Criteria Met

No Metabolic
Syndrome (2 or
fewer criteria)
(N=636)
3 Criteria
(N=349)
4 Criteria
(N=1094)
5 Criteria
(N=1298)
P-value(1) P-value(2)
Randomized Treatment Assignment Monotherapy 335 (52.7%) 183 (52.4%) 524 (47.9%) 633 (48.8%) 0.085 0.334
Combination Therapy 301 (47.3%) 166 (47.6%) 570 (52.1%) 665 (51.2%)
Demographics, baseline physical exam and laboratory measures:
  Age N 636 349 1094 1298 0.052 <.001*
Mean (Std Dev) 63.1 (9.2) 62.6 (9.3) 63.4 (8.6) 64.5 (8.4)
  Gender Female 75 (11.8%) 46 (13.2%) 152 (13.9%) 230 (17.7%) 0.015* 0.015*
Male 561 (88.2%) 303 (86.8%) 942 (86.1%) 1068 (82.3%)
  Race American Indian/Alaska Native/Aboriginal Canadian 1 (0.2%) 1 (0.3%) 4 (0.4%) 15 (1.2%) 0.186 0.002*
Asian 9 (1.4%) 10 (2.9%) 15 (1.4%) 6 (0.5%)
Black/African American 21 (3.3%) 6 (1.7%) 40 (3.7%) 49 (3.8%)
Native Hawaiian or Other Pacific Islander 4 (0.6%) 1 (0.3%) 1 (0.1%) 6 (0.5%)
White 593 (93.2%) 323 (92.6%) 1008 (92.1%) 1192 (91.8%)
Muti-racial or Other 8 (1.3%) 8 (2.3%) 25 (2.3%) 30 (2.3%)
  Ethnicity Not Hispanic or Latino 621 (97.6%) 339 (97.1%) 1053 (96.3%) 1224 (94.3%) 0.013* 0.025*
Hispanic or Latino 15 (2.4%) 10 (2.9%) 41 (3.7%) 73 (5.6%)
  Systolic blood pressure (mmHg) N 636 349 1093 1297 <.001* <.001*
Mean (Std Dev) 121.7 (15.1) 128.1 (15.4) 128.6 (16.1) 131.1 (16.4)
Median (25th, 75th%-tile) 120.0 (110.0, 129.0) 128.0 (117.0, 138.0) 128.0 (118.0, 139.0) 130.0 (120.0, 141.0)
  Diastolic blood pressure (mmHg) N 636 349 1093 1297 <.001* 0.224
Mean (Std Dev) 71.8 (9.5) 75.7 (9.4) 75.0 (9.4) 74.7 (10.1)
Median (25th, 75th%-tile) 71.0 (67.0, 78.0) 76.0 (70.0, 82.0) 74.0 (70.0, 80.0) 75.0 (68.0, 80.0)
  Body Mass Index (kg/m2) N 635 349 1091 1297 <.001* <.001*
Mean (Std Dev) 27.8 (3.9) 28.7 (4.6) 31.2 (5.1) 33.6 (5.1)
Median (25th, 75th%-tile) 27.0 (25.0, 30.0) 28.0 (26.0, 30.0) 30.0 (28.0, 34.0) 33.0 (30.0, 36.0)
  Waist circumference (inches) N 630 348 1093 1296 <.001* <.001*
Mean (Std Dev) 38.1 (4.1) 39.7 (4.4) 42.4 (4.9) 45.1 (4.6)
Median (25th, 75th%-tile) 38.0 (35.8, 40.0) 39.0 (37.0, 42.0) 42.0 (39.0, 45.7) 44.1 (42.0, 48.0)
  Glucose (mg/dL) N 636 346 1094 1298 <.001* <.001*
Mean (Std Dev) 96.9 (10.5) 99.0 (16.4) 110.3 (21.9) 120.9 (23.7)
Median (25th, 75th%-tile) 97.0 (91.0, 103.0) 96.0 (91.0, 99.0) 104.5 (95.0, 123.0) 116.0 (105.0, 134.0)
  Insulin (mg/dL) N 635 348 1090 1294 <.001* <.001*
Mean (Std Dev) 13.3 (13.4) 14.7 (11.3) 18.8 (18.4) 26.1 (35.0)
Median (25th, 75th%-tile) 10.2 (7.0, 15.6) 12.6 (7.9, 18.5) 14.4 (9.3, 22.5) 18.3 (12.2, 28.6)
  HOMA1-IR N 635 345 1090 1294 <.001* <.001*
Mean (Std Dev) 3.2 (3.3) 3.6 (2.9) 5.2 (5.5) 7.9 (11.1)
Median (25th, 75th%-tile) 2.4 (1.7, 3.8) 2.9 (1.9, 4.5) 3.8 (2.4, 6.0) 5.4 (3.4, 8.5)
History of diabetes 64 (10.1%) 27 (7.7%) 320 (29.3%) 744 (57.3%) <.001* <.001*
(1)

Comparison between no metabolic syndrome and any number of criteria

(2)

Comparison among 3, 4, or 5 criteria met